Dry granulation of biopharmaceutical raw materials like urea and glycine significantly reduces caking and improves handling efficiency compared to bulk materials, even under challenging storage conditions. The granulated products demonstrated enhanced mechanical stability and flowability, despite slightly longer dissolution times. These improvements facilitate manufacturing processes, reduce disruptions, and enhance operator safety.
Related topics: